To Study the Prevalence and Association of Thyroid Disorders in Patients with Type 2 Diabetes Mellitus
Authors
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
Background: Thyroid dysfunction is a significant comorbidity in type 2 diabetes mellitus, disrupting the metabolic balance and increasing the disease burden. The objective of the study was to assess the prevalence and association of thyroid disorders in patients with type 2 diabetes mellitus. Materials and Methods: A case control study was conducted among 100 patients with type 2 diabetes mellitus and 100 controls attending the outpatient department (OPD) and wards of Department of Endocrinology, Index Medical College, Hospital and Research Center, Indore, Madhya Pradesh. The study was done over a period of 21 months from July 2023 to March 2025. The study was done after obtaining ethical approval from the Institutional Ethics Committee. Results: The mean age of the participants in the diabetic group was 52.14 ± 17.86 years and the control group was 52.07 ± 17.62 years. The gender distribution in the study population had 51% females. Subclinical hypothyroidism was the most common thyroid dysfunction found in type 2 diabetes mellitus patients. The prevalence of thyroid dysfunction in the study was 28% in patients with type 2 diabetes mellitus. Thyroid dysfunction is more prevalent in individuals with type 2 diabetes mellitus compared to non-diabetics.Conclusion: The study highlights the importance of thyroid screening and awareness among individuals with type 2 diabetes mellitus. It also underlines the need for holistic evaluation strategies that goes beyond glycaemic indices to ensure comprehensive metabolic care. The healthcare providers should foster strategies to ensure detection of thyroid dysfunction among diabetic individuals and optimize management so as to potentially improve outcomes for those individuals at risk.
##plugins.themes.bootstrap3.article.details##
Copyright (c) 2025 Deepak Dhakal, Medo M. Kuotsu, Ajay Gupta, Abhyudaya Verma, Divyansh Malik
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons License All articles published in Annals of Medicine and Medical Sciences are licensed under a Creative Commons Attribution 4.0 International License.
Deepak Dhakal, Senior Resident, Department of Endocrinology, Index Medical College, Hospital and Research Center, Indore, Madhya Pradesh, India.
Senior Resident, Department of Endocrinology, Index Medical College, Hospital and Research Center, Indore, Madhya Pradesh, India.
Medo M. Kuotsu, Assistant Professor, Department of General Medicine, Nagaland Institute of Medical Sciences and Research, Kohima, Nagaland, India.
Assistant Professor, Department of General Medicine, Nagaland Institute of Medical Sciences and Research, Kohima, Nagaland, India.
Ajay Gupta, Professor and HoD, Department of Endocrinology, Index Medical College, Hospital and Research Center, Indore, Madhya Pradesh, India.
Professor and HoD, Department of Endocrinology, Index Medical College, Hospital and Research Center, Indore, Madhya Pradesh, India.
Abhyudaya Verma, Associate Professor, Department of Endocrinology, Index Medical College, Hospital and Research Center, Indore, Madhya Pradesh, India.
Associate Professor, Department of Endocrinology, Index Medical College, Hospital and Research Center, Indore, Madhya Pradesh, India.
Divyansh Malik, Senior Resident, Department of Endocrinology, Index Medical College, Hospital and Research Center, Indore, Madhya Pradesh, India.
Senior Resident, Department of Endocrinology, Index Medical College, Hospital and Research Center, Indore, Madhya Pradesh, India.
[1] NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016 Apr 9;387(10027):1513-1530. doi: 10.1016/S0140-6736(16)00618-8
[2] Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018 Apr;138:271-281. doi: 10.1016/j.diabres.2018.02.023.
[3] Kuotsu MM, Khezhie A, Dhakal D. Knowledge of Hypoglycemia Symptoms Among Type 2 Diabetes Mellitus Patients at NIMSR Kohima. AMMS [Internet]. 2025 Jun. 25:497-500. Available from: https://ammspub.com/index.php/amms/article/view/209
[4] Grigoriadis G, Koufakis T, Kotsa K. Epidemiological, Pathophysiological, and Clinical Considerations on the Interplay between Thyroid Disorders and Type 2 Diabetes Mellitus. Medicina (Kaunas). 2023 Nov 16;59(11):2013.
[5] Brenta G. Why can insulin resistance be a natural consequence of thyroid dysfunction? J Thyroid Res. (2011) 2011:152850. doi: 10.4061/2011/152850
[6] Asuti S, Purad S, Hosamani P: Pattern of thyroid dysfunction in type ii diabetes mellitus patients in a tertiary care center: a cross-sectional study. J Med Sci Heal. 2023, 9:204-10. 10.46347/jmsh.v9i2.23.125
[7] Stanická S, Vondra K, Pelikánová T, et al. Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy. Clin Chem Lab Med 2005;43(7):715–720.
[8] Wang C. The Relationship between Type 2 Diabetes Mellitus and Related Thyroid Diseases. J Diabetes Res. 2013;2013:390534.
[9] Chen HSS, Wu T, Jap TSS, Lu RAA, Wang MLL, Chen RLS, et al. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients. Diabetic Medicine. 2007;24(12):1336–1344.
[10] Hecht A, Gershberg H. Diabetes mellitus and primary hypothyroidism. Metabolism. 1968;17(2):108–113. doi:10.1016/ 0026-0495(68)90136-47
[11] Papazafiropoulou A, Sotiropoulos A, Kokolaki A, Kardara M, Stamataki P, Pappasa S. Prevalence of Thyroid Dysfunction Among Greek Type 2 Diabetic Patients Attending an Outpatient Clinic. Journal of Clinical Medicine Research. 2010;2(2):75–78.
[12] Rae P, Farrar J, Beckett G, Toft A. Assessment of thyroid status in elderly people. BMJ. 1993;307:177–180. doi:10.1136/bmj.307.68 97.177
[13] Demitrost L, Ranabir S. Thyroid dysfunction in type 2 diabetes mellitus: A retrospective study. Indian J Endocrinol Metab. 2012;16(Suppl 2):S334–S335. doi:10.4103/2230-8210.104080
[14] Proces S, Delgrange E, Vander Borght TV, Jamart J, Donckier JE. Minor alterations in thyroid‑function tests associated with diabetes mellitus and obesity in outpatients without known thyroid illness. Acta Clin Belg 2001;56:86‑90.
[15] Bhattacharjee R, Thukral A, Chakraborty PP, Roy A, Goswami S, Ghosh S, et al. Effects of thyroid status on glycated hemoglobin. Indian Journal of Endocrinology and Metabolism. 2017;21(1):26–30. Available from: https://doi.org/10.4103/2230-8210.196017.
[16] Jain G, Marwaha TS, Khurana A, Dhoat PS. Prevalence of thyroid disorders in patients of type 2 diabetes mellitus. Int J Med Dent Sci. 2013;2(2):153–161.
[17] Díez JJ, Sánchez P, Iglesias P. Prevalence of thyroid dysfunction in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 2011;119:201‑7.
[18] Vikhe VB, Kanitkar SA, Tamakuwala KK, Gaikwad AN, Kalyan M, Agarwal RR. Thyroid dysfunction in patients with type 2 diabetes mellitus at tertiary care centre. Natl J Med Res 2013;3:377‑80.
[19] Zhu Y, Xu F, Shen J, et al. Prevalence of thyroid dysfunction in older Chinese patients with type 2 diabetes—A multicenter cross-sectional observational study across China. PLoS One. 2019;14(5):e0216151. doi:10.1371/journal.pone.021615128.
[20] Telwani AA, Wani ZH, Ashraf Y, Shah AA. Prevalence of thyroid dysfunction in type 2 diabetes mellitus: a case control study. Int J Res Med Sci 2017;5:4527-31.